Introduction
============

The *Staphylococcus intermedius* group (SIG), previously called \'*Staphylococcus* (*S*.) *intermedius*\', is an opportunistic bacterium that is most frequently associated with skin diseases such as pyoderma and otitis externa in dogs \[[@B9]\]. The SIG inhabiting skin includes three species: *S. pseudintermedius* (SP), *S. intermedius*, and *S. delphini*. These coagulase-positive staphylococci (CoPS) have similar phenotypes and differentiation among CoPS has relied on molecular identification techniques \[[@B17]\]. In companion dogs, the SIG seems to consist solely of SP \[[@B17],[@B31]\]. The SIG is also known to be a primary pathogen that causes canine ocular diseases such as keratitis and abscess; however, little information is available about the prevalence of SP in canine ophthalmic microflora \[[@B24],[@B27],[@B28]\].

The SIG bacterium disrupts cell-to-cell adhesion of eukaryotic cells during skin infection by producing a 27-kDa exfoliative toxin (*siet*) that targets a desmosomal cell-cell adhesion molecule in the superficial epidermis (desmoglein 1) and facilitates percutaneous bacterial invasion of mammalian skin \[[@B15],[@B23]\]. In recent studies, methicillin resistance and multi-drug resistance (MDR) in animal pathogenic *Staphylococcal* spp. have been implicated in potential zoonotic infections among humans \[[@B20],[@B21],[@B32]\]. In particular, *mecA* has been closely linked with MDRSP or methicillin-resistant SP (MRSP), thereby decreasing the arsenal of effective antibiotics \[[@B6],[@B10],[@B30],[@B31]\]. The zoonotic transfer of MDRSP and MRSP could critically impact public health. The indiscriminate use of broad-spectrum systemic or topical antibiotics for therapeutic purposes and as a prophylaxis against ocular disease could increase bacteria resistance and zoonotic potential \[[@B27]\]. However, limited data on the prevalence of ophthalmic MDRSP and MRSP is available in veterinary practice and literature. The purpose of this study was to evaluate the prevalence and antibiotic resistance of SP isolates from canine eyes, and identify potential virulence genes using molecular techniques.

Materials and Methods
=====================

Collection of the staphylococcal strains
----------------------------------------

Sixty-seven staphylococcal strains were isolated from individual canine eyes between March 2005 and September 2007 using a standard bacteriological method. Collection of the isolates was performed at the Veterinary Medical Teaching Hospital of Konkuk University (Korea). Thirty-three dogs referred for ocular disease were treated or suspected of having been treated with antibiotics. Ocular diseases included corneal ulcer, conjunctivitis, keratoconjunctivitis sicca, uveititis, keratoconjunctivitis, blepharitis, glaucoma, corneal degeneration, conjunctival hyperemia, ocular hemorrhage, cataract, progressive retinal atrophy, and retinal detachment. Other dogs were referred for non-ocular disease, and no information was available. Two cotton-tipped culture swabs were taken from each dog. Preliminarily screening was conducted using standard microbiological procedures including a phenotypical test, Gram staining, and a catalase test to differentiate staphylococcal species.

Multiplex PCR and molecular identification
------------------------------------------

Bacterial DNA extraction was performed by inoculating Luria-Bertani (LB) medium with a single colony and incubating overnight at 37℃. Next, 1.5 mL of the cultured medium was centrifuged at 12,000 × g for 1 min. The bacterial pellet was then suspended in 500 µL of Tris-EDTA (10 mM Tris, pH 8.0, and 0.1 mM EDTA) buffer and DNA was extracted using a commercial kit (Optima Scientific, Japan).

PCR-based confirmation of SIG was carried out with species-specific primers targeting the SIG nuclease (*nuc*) gene as previously described \[[@B2]\]. Additionally, PCR reactions specific for the *siet*, *mecA*, and *blaZ* genes were performed to identify exfoliative toxin production, oxacillin resistance, and penicillin resistance, respectively, as previously described \[[@B14],[@B22]\]. Five primer pairs were used for our multiplex PCR and the *blaZ* gene-targeting primers were modified to distinguish the amplicon of interest from other amplicons based on size. The oligonucleotide primer sequences and PCR programs are summarized in [Table 1](#T1){ref-type="table"}.

After primer modification, the amplicon size of the *blaZ* gene was about 700 bp. The PCR-amplified products were subsequently analyzed by direct DNA sequencing (Macrogen, Korea). All of the multiplex PCR amplicons were the expected size when the DNA templates were 10\~10^-1^ ng. The amplicons were between 125 and 700 bp in size, and correctly differentiated by agarose gel electrophoresis.

For this study, we mixed 2 ng of the template DNA from the 67 samples with 12.5 µL of 2× EF-Taq PCR Pre-Mix (SolGent, Korea). Next, 2.5 pmol of 16S primers or 10 pmol of the other primers were added to amplify the gene-specific PCR fragment. The PCR conditions are described in [Table 1](#T1){ref-type="table"}. To identify the PCR product, we separated 10 µL of the reaction product in a 2% agarose gel by electrophoresis and stained with ethidium bromide for visualization. A 16S rDNA primer pair specific for *Staphylococcus* functioned as the internal control, confirming the amplification efficiency ([Fig. 1](#F1){ref-type="fig"}).

PCR-restriction fragment length polymorphism (PCR-RFLP) analysis of the *pta* gene was performed for SP identification. Following a previously described protocol \[[@B1]\], we used *pta* primers and MboI restriction enzyme. The concentrations of the primers, template DNA, and restriction enzyme were modified along with the PCR product volume to increase the reaction efficiency. We mixed 2 ng of template DNA with 15 µL of 2× SolGent EF-Taq PCR Pre-Mix, 10 pmol of the *pta* primers, and 11 µL of distilled water. The PCR conditions are described in [Table 1](#T1){ref-type="table"}. After post-extension, we mixed 5 µL of the PCR product with 2 µL of 10× NE buffer 4 (50 mM potassium-acetate, 20 mM Tris-acetate, 10 mM Mg-acetate, 1 mM DTT, pH 7.9), 1 U of MboI restriction enzyme, and 12 µL of distilled water. The solution was then incubated at 37℃ for 4 h. SP was identified based on the detection of 107 and 203 bp *pta* gene fragments ([Fig. 2](#F2){ref-type="fig"}).

Antimicrobial susceptibility testing
------------------------------------

An antibiogram analysis was carried out following the guidelines of the Clinical and Laboratory Standards Institute \[[@B5]\]. Eight commonly prescribed antibiotics were tested \[amoxicillin/clavulanic acid (30 µg), oxacillin (1 µg), chloramphenicol (30 µg), gentamycin (10 µg), erythromycin (15 µg), sulfametoxazole/trimethoprim (25 µg), tetracycline (30 µg), and penicillin (10 µg)\] using commercially available BD BBL Sensi-Disc disks (BD Diagnostics, USA).

Results
=======

According to the multiplex PCR results, eight groups were identified based on the prevalence of the *SInuc*, *siet*, *blaZ*, and *mecA* genes ([Fig. 1](#F1){ref-type="fig"}; [Table 2](#T2){ref-type="table"}). The 16S rDNA gene amplicon internal control was clearly positive for all 67 strains. Among these, 50 strains (74.6%) in groups 1 to 3 contained the *SInuc* gene specific for SIG. Out of the 50 ophthalmic SP strains, 25 were isolated from dogs with ocular disease and the other 25 were isolated from dogs without ocular disease. Similar to a previous report \[[@B26]\], all SIG strains were confirmed as SP according to the PCR-RFLP assay and all SP-encoded exfoliative toxin-producing genes were predominantly found in the ophthalmic SP strains. None of the *SInuc* gene-negative strains were identified as SP. The *blaZ* antibiotic resistance gene was present in 46 of the 50 SP strains (94%). Among these, 18 strains (36%) also contained the *mecA* gene. Notably, none of the *blaZ* gene-negative strains expressed the *mecA* gene ([Table 2](#T2){ref-type="table"}). Prevalence of the *mecA* gene was twice as high in SP isolated from dogs with ocular disease (12/25, 48%) compared to ones without (6/25, 24%).

Susceptibility to eight commonly used antibiotics of the 50 SP isolates is presented in [Table 3](#T3){ref-type="table"}. More than 50% of the SP isolates were resistant to tetracycline, penicillin, sulfamethoxazole/trimethoprim, erythromycin, and gentamycin. The levels of susceptibility were highest for amoxicillin/clavulanic acid and chloramphenicol. Seventeen of the 50 (34%) SP strains were resistant to oxacillin, indicating a high prevalence of MRSP ([Table 3](#T3){ref-type="table"}).

There was significant correlation between genes conferring antibiotic resistance (*mecA* and *blaZ*) and antibiotic susceptibility (penicillin and oxacillin). The 18 *mecA*-ositive and *blaZ*-positive strains were 100% resistant to penicillin. Most of the 18 *mecA*-positive strains were resistant to oxacillin (88.9%). However, only 37% of the 46 *blaZ*-positive strains were resistant to this reagent. Based on these results, antimicrobial resistance of the 50 ophthalmic SP isolates was re-evaluated based on the presence of the *mecA* gene. Among the *mecA*-positive isolates (18/50), most oxacillin-resistant SP strains (16/18) were also resistant to multiple antibiotics such as tetracycline, sulfamethoxazole/trimethoprim, erythromycin, and gentamycin. Additionally, two of the *mecA*-positive SP strains were oxacillin susceptible and one *mecA*-negative SP strain was resistant to oxacillin ([Table 4](#T4){ref-type="table"}). All *mecA*-positive SP isolates were resistant to more than four of the eight tested antibiotics, indicating an association of MDRSP with *mecA* gene-ositive SP ([Fig. 3](#F3){ref-type="fig"}).

Discussion
==========

All ophthalmic SIG isolates (50/67, 74.6%) in this study were re-identified as SP. These results were similar with ones from a study on skin-derived SIG \[[@B30]\]. It has been suggested that SP is highly host-specific and foot-to-eye transmission is possible. Universal prevalence of exfoliative toxin-producing genes among the SP strains examined in the current investigation strongly implies the high possibility that these bacteria can cause ophthalmic disease \[[@B14]\].

The prevalence of MRSP has been commonly studied in dogs and cats with skin disease \[[@B26]\]. According to a recent report, the prevalence of MRSP in North America and Canada is 0%\~7% \[[@B26]\]. These rates are slightly elevated in other countries with 12.7% in China \[[@B29]\], 11.4% in Japan \[[@B16]\], and 17.6% in Korea \[[@B31]\]. In the present investigation, the MRSP rate was 34%, which was higher than that previously reported in studies of skin. The frequent use of broad-spectrum antibiotics as canine ocular medications could have contributed to the relatively high prevalence of MRSP we observed although the exact history of antibiotic administration was not obtained for our survey.

In the current study, 46 out of 50 (92%) SP isolates possessed the *blaZ* gene while 18 out of 50 (36%) had the *mecA* gene. These two genes are specific for *Staphylococcus* penicillin- and oxacillin-like β-lactam antibiotic resistance. Furthermore, prevalence of the *mecA* gene was approximately two-times higher among dogs with ocular diseases. These results indicate a high rate of antibiotic resistance genes in ophthalmic SP. Among the 50 SP strains, 16 (32%) of the oxacillin-resistant isolates possessing the *mecA* gene were twice as likely to be resistant to the three most susceptible antibiotics, suggesting that the *mecA* gene is closely associated with MDR \[[@B11],[@B12]\]. The increased prevalence of SP harboring the *mecA* gene could thus impact patient health since the antibiotic choices for therapy would be narrowed.

Two out of the 18 SP isolates harboring the *mecA* gene were susceptible to methicillin and therefore classified as pre-MRSP \[[@B3]\]. Pre-MRSP strains contain a functionally intact mecR1-mecI regulatory region. As a result, *mecA* expression might be strongly repressed. Under antibiotic pressure, such pre-MRSPs tend to constitutively produce penicillin-binding protein (PBP2a) and acquire increased resistance to methicillin.

One strain was negative for the *mecA* gene but methicillin-resistant (1/32, 3.1%). It is possible that the hyperproduction of β-lactamase or PBPs alternatively produced by another type of antibiotic resistance gene could help the bacteria resist oxacillin-like β-lactam antibiotics in the absence of the *mecA* gene \[[@B8],[@B25]\]. In 2011, a novel *mecA* homologue designated mecC (or *mecA~LGA251~*) was described \[[@B7]\]. Because of its highly divergent sequence, this gene cannot be detected by routine molecular assays designed to identify *mecA* \[[@B13],[@B18]\]. This suggests that a different *mec* element not detectable by conventional *mecA*-specific PCR could be involved. Further study of these mechanisms will be helpful for developing new drugs that target β-lactam-resistant *Staphylococcus*.

In this study, we described a multiplex PCR procedure to detect clinically relevant antibiotic resistance genes in ophthalmic SP isolates. Although classical susceptibility testing methods are relatively simple, the results may be highly dependent on experimental conditions. Furthermore, there is no certain way to determine antibiotic concentrations in ocular tissues during topical therapy. Results of our multiplex PCR assay were comparable to ones from the standard susceptibility test performed in this study. A recent Clinical and Laboratory Standards Institute (CLSI) recommendation \[[@B5]\] is germane to the discrepancy observed between the *mecA* gene prevalence and oxacillin resistance we observed. According to this recommendation, strains of *S. aureus* and *S. lugdunensis* should be reported as oxacillin-resistant if either disc result indicates resistance when both cefoxitin and oxacillin are tested. Indeed, some studies have reported that a 30-µg cefoxitin disc is more sensitive than a 1-µg oxacillin disc when detecting *mecA*-mediated oxacillin resistance among staphylococci \[[@B4],[@B19]\]. However, pre- MRSP and *mecA*-negative oxacillin-resistant SP strains were also sensitive to cefoxitin in the present study (data not shown). Thus, we recommend that both an oxacillin disc test and PCR detection should be performed together to identify ophthalmic MRSP. In addition, multiplex PCR detection could provide more information for developing an effective antibiotic therapy.

In conclusion, results of our study demonstrated that ophthalmic MDRSP and MRSP were prevalent in dogs. The phenotypic and genotypic comparison of antibiotic resistance showed that 88.9% of all the *mecA*-positive SP isolates was resistant to oxacillin. Notably, all the *mecA*-positive and oxacillin-resistant SP isolates displayed MDR. Based on our findings, we strongly recommend that judicious selection of antibiotics in companion dogs is necessary to prevent MDR.
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###### 

Oligonucleotide sequences and PCR conditions used in the present study
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^\*^PCR program 1: one cycle at 95° for 240 sec, 30 cycles at 95℃ for 60 sec, 58℃ for 60 sec, and 72℃ for 60 sec; one cycle at 72℃ for 420 sec. ^†^PCR program 2: one cycle at 95℃ for 120 sec, 30 cycles at 95℃ for 60 sec, 53℃ for 60 sec, and 72℃ for 60 sec; one cycle at 72℃ for 420 sec.

###### 

Multiplex PCR and PCR-RFLP results for the 67 *Staphylococcus* species isolated from canine eyes
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###### 

Antibiogram results for the 50 ophthalmic SP isolates

![](jvs-15-409-i003)

###### 

Antimicrobial resistance of the *mecA*-positive or -negative ophthalmic SP isolates from dogs
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^\*^Oxa-R, resistant to oxacillin according to the disk diffusion assay; ^†^Oxa-susc, susceptible or intermediate resistance to oxacillin according to the disc diffusion assay.
